Return to Trial Database

HCRN-CUP16-268

Single-arm phase 2 study to examine pembrolizumab and concurrent radiation to induce an abscopal effect in patients with previously treated carcinoma of unknown primary (CUP16-268)

Status

Study Completed

Cancer Type(s)

Carcinoma of Unknown Primary

Study Contact

Trial Locations

All sites in which the trial HCRN-CUP16-268 being conducted in.

No data was found